Concepedia

Frederick C. Kull

FC

Statistics

Publications

35

Citations

3.4K

H-Index

23

Active since

1947

Affiliations

Research Triangle Park Foundation(Current)

Burroughs Wellcome Fund

GlaxoSmithKline (United Kingdom)

Summit School

GlaxoSmithKline (United States)

Frederick C. Kull is an author at Research Triangle Park Foundation specializing in life sciences, pharmacology, and medicine.

Publications per year

1947–2005

35

Publications

35

Monoclonal antibodies to receptors for insulin and somatomedin-C.

Frederick C. Kull, Steven Jacobs, Y F Su et al. · Journal of Biological Chemistry · 1983 · 422 citations · Full text

, , +12

Myostatin inhibits cell proliferation and protein synthesis in C<sub>2</sub>C<sub>12</sub> muscle cells

Wayne E. Taylor, Shalender Bhasin, Jorge Artaza et al. · American Journal of Physiology-Endocrinology and Metabolism · 2001 · 402 citations

, , +15

Somatomedin-C stimulates the phosphorylation of the beta-subunit of its own receptor.

Steven Jacobs, Frederick C. Kull, H. Shelton Earp et al. · Journal of Biological Chemistry · 1983 · 396 citations · Full text

, , +10

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

Carlos L. Arteaga, Libbey J. Kitten, Ester B. Coronado et al. · Journal of Clinical Investigation · 1989 · 329 citations · Full text

, , +9

Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.

Frederick C. Kull, Steven Jacobs, P Cuatrecasas · Proceedings of the National Academy of Sciences · 1985 · 281 citations · Full text

, , +11

1–5 of 35